1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Hospital Injectable Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Generic Sterile Injectables 1.2.3 Sterile Intravenous (IV) Solutions 1.3 Market by Application 1.3.1 Global Hospital Injectable Drugs Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Oncology 1.3.3 Anesthesia 1.3.4 Anti-Infectives 1.3.5 Parenteral Nutrition 1.3.6 Cardiovascular Diseases 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Hospital Injectable Drugs Market Perspective (2016-2027) 2.2 Hospital Injectable Drugs Growth Trends by Regions 2.2.1 Hospital Injectable Drugs Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Hospital Injectable Drugs Historic Market Share by Regions (2016-2021) 2.2.3 Hospital Injectable Drugs Forecasted Market Size by Regions (2022-2027) 2.3 Hospital Injectable Drugs Industry Dynamic 2.3.1 Hospital Injectable Drugs Market Trends 2.3.2 Hospital Injectable Drugs Market Drivers 2.3.3 Hospital Injectable Drugs Market Challenges 2.3.4 Hospital Injectable Drugs Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Hospital Injectable Drugs Players by Revenue 3.1.1 Global Top Hospital Injectable Drugs Players by Revenue (2016-2021) 3.1.2 Global Hospital Injectable Drugs Revenue Market Share by Players (2016-2021) 3.2 Global Hospital Injectable Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Hospital Injectable Drugs Revenue 3.4 Global Hospital Injectable Drugs Market Concentration Ratio 3.4.1 Global Hospital Injectable Drugs Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Hospital Injectable Drugs Revenue in 2020 3.5 Hospital Injectable Drugs Key Players Head office and Area Served 3.6 Key Players Hospital Injectable Drugs Product Solution and Service 3.7 Date of Enter into Hospital Injectable Drugs Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Hospital Injectable Drugs Breakdown Data by Type 4.1 Global Hospital Injectable Drugs Historic Market Size by Type (2016-2021) 4.2 Global Hospital Injectable Drugs Forecasted Market Size by Type (2022-2027) 5 Hospital Injectable Drugs Breakdown Data by Application 5.1 Global Hospital Injectable Drugs Historic Market Size by Application (2016-2021) 5.2 Global Hospital Injectable Drugs Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Hospital Injectable Drugs Market Size (2016-2027) 6.2 North America Hospital Injectable Drugs Market Size by Type 6.2.1 North America Hospital Injectable Drugs Market Size by Type (2016-2021) 6.2.2 North America Hospital Injectable Drugs Market Size by Type (2022-2027) 6.2.3 North America Hospital Injectable Drugs Market Size by Type (2016-2027) 6.3 North America Hospital Injectable Drugs Market Size by Application 6.3.1 North America Hospital Injectable Drugs Market Size by Application (2016-2021) 6.3.2 North America Hospital Injectable Drugs Market Size by Application (2022-2027) 6.3.3 North America Hospital Injectable Drugs Market Size by Application (2016-2027) 6.4 North America Hospital Injectable Drugs Market Size by Country 6.4.1 North America Hospital Injectable Drugs Market Size by Country (2016-2021) 6.4.2 North America Hospital Injectable Drugs Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Hospital Injectable Drugs Market Size (2016-2027) 7.2 Europe Hospital Injectable Drugs Market Size by Type 7.2.1 Europe Hospital Injectable Drugs Market Size by Type (2016-2021) 7.2.2 Europe Hospital Injectable Drugs Market Size by Type (2022-2027) 7.2.3 Europe Hospital Injectable Drugs Market Size by Type (2016-2027) 7.3 Europe Hospital Injectable Drugs Market Size by Application 7.3.1 Europe Hospital Injectable Drugs Market Size by Application (2016-2021) 7.3.2 Europe Hospital Injectable Drugs Market Size by Application (2022-2027) 7.3.3 Europe Hospital Injectable Drugs Market Size by Application (2016-2027) 7.4 Europe Hospital Injectable Drugs Market Size by Country 7.4.1 Europe Hospital Injectable Drugs Market Size by Country (2016-2021) 7.4.2 Europe Hospital Injectable Drugs Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Hospital Injectable Drugs Market Size (2016-2027) 8.2 Asia-Pacific Hospital Injectable Drugs Market Size by Type 8.2.1 Asia-Pacific Hospital Injectable Drugs Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Hospital Injectable Drugs Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Hospital Injectable Drugs Market Size by Type (2016-2027) 8.3 Asia-Pacific Hospital Injectable Drugs Market Size by Application 8.3.1 Asia-Pacific Hospital Injectable Drugs Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Hospital Injectable Drugs Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Hospital Injectable Drugs Market Size by Application (2016-2027) 8.4 Asia-Pacific Hospital Injectable Drugs Market Size by Region 8.4.1 Asia-Pacific Hospital Injectable Drugs Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Hospital Injectable Drugs Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Hospital Injectable Drugs Market Size (2016-2027) 9.2 Latin America Hospital Injectable Drugs Market Size by Type 9.2.1 Latin America Hospital Injectable Drugs Market Size by Type (2016-2021) 9.2.2 Latin America Hospital Injectable Drugs Market Size by Type (2022-2027) 9.2.3 Latin America Hospital Injectable Drugs Market Size by Type (2016-2027) 9.3 Latin America Hospital Injectable Drugs Market Size by Application 9.3.1 Latin America Hospital Injectable Drugs Market Size by Application (2016-2021) 9.3.2 Latin America Hospital Injectable Drugs Market Size by Application (2022-2027) 9.3.3 Latin America Hospital Injectable Drugs Market Size by Application (2016-2027) 9.4 Latin America Hospital Injectable Drugs Market Size by Country 9.4.1 Latin America Hospital Injectable Drugs Market Size by Country (2016-2021) 9.4.2 Latin America Hospital Injectable Drugs Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Hospital Injectable Drugs Market Size (2016-2027) 10.2 Middle East & Africa Hospital Injectable Drugs Market Size by Type 10.2.1 Middle East & Africa Hospital Injectable Drugs Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Hospital Injectable Drugs Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Hospital Injectable Drugs Market Size by Type (2016-2027) 10.3 Middle East & Africa Hospital Injectable Drugs Market Size by Application 10.3.1 Middle East & Africa Hospital Injectable Drugs Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Hospital Injectable Drugs Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Hospital Injectable Drugs Market Size by Application (2016-2027) 10.4 Middle East & Africa Hospital Injectable Drugs Market Size by Country 10.4.1 Middle East & Africa Hospital Injectable Drugs Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Hospital Injectable Drugs Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Hospira (Pfizer Inc.) 11.1.1 Hospira (Pfizer Inc.) Company Details 11.1.2 Hospira (Pfizer Inc.) Business Overview 11.1.3 Hospira (Pfizer Inc.) Hospital Injectable Drugs Introduction 11.1.4 Hospira (Pfizer Inc.) Revenue in Hospital Injectable Drugs Business (2016-2021) 11.1.5 Hospira (Pfizer Inc.) Recent Development 11.2 Baxter 11.2.1 Baxter Company Details 11.2.2 Baxter Business Overview 11.2.3 Baxter Hospital Injectable Drugs Introduction 11.2.4 Baxter Revenue in Hospital Injectable Drugs Business (2016-2021) 11.2.5 Baxter Recent Development 11.3 Fresenius Kabi 11.3.1 Fresenius Kabi Company Details 11.3.2 Fresenius Kabi Business Overview 11.3.3 Fresenius Kabi Hospital Injectable Drugs Introduction 11.3.4 Fresenius Kabi Revenue in Hospital Injectable Drugs Business (2016-2021) 11.3.5 Fresenius Kabi Recent Development 11.4 Sandoz (Novartis) 11.4.1 Sandoz (Novartis) Company Details 11.4.2 Sandoz (Novartis) Business Overview 11.4.3 Sandoz (Novartis) Hospital Injectable Drugs Introduction 11.4.4 Sandoz (Novartis) Revenue in Hospital Injectable Drugs Business (2016-2021) 11.4.5 Sandoz (Novartis) Recent Development 11.5 Hikma Pharmaceuticals PLC 11.5.1 Hikma Pharmaceuticals PLC Company Details 11.5.2 Hikma Pharmaceuticals PLC Business Overview 11.5.3 Hikma Pharmaceuticals PLC Hospital Injectable Drugs Introduction 11.5.4 Hikma Pharmaceuticals PLC Revenue in Hospital Injectable Drugs Business (2016-2021) 11.5.5 Hikma Pharmaceuticals PLC Recent Development 11.6 Dr. Reddy’s Laboratories Ltd 11.6.1 Dr. Reddy’s Laboratories Ltd Company Details 11.6.2 Dr. Reddy’s Laboratories Ltd Business Overview 11.6.3 Dr. Reddy’s Laboratories Ltd Hospital Injectable Drugs Introduction 11.6.4 Dr. Reddy’s Laboratories Ltd Revenue in Hospital Injectable Drugs Business (2016-2021) 11.6.5 Dr. Reddy’s Laboratories Ltd Recent Development 11.7 Grifols 11.7.1 Grifols Company Details 11.7.2 Grifols Business Overview 11.7.3 Grifols Hospital Injectable Drugs Introduction 11.7.4 Grifols Revenue in Hospital Injectable Drugs Business (2016-2021) 11.7.5 Grifols Recent Development 11.8 Nichi-Iko Group (Sagent) 11.8.1 Nichi-Iko Group (Sagent) Company Details 11.8.2 Nichi-Iko Group (Sagent) Business Overview 11.8.3 Nichi-Iko Group (Sagent) Hospital Injectable Drugs Introduction 11.8.4 Nichi-Iko Group (Sagent) Revenue in Hospital Injectable Drugs Business (2016-2021) 11.8.5 Nichi-Iko Group (Sagent) Recent Development 11.9 Teva Pharmaceutical 11.9.1 Teva Pharmaceutical Company Details 11.9.2 Teva Pharmaceutical Business Overview 11.9.3 Teva Pharmaceutical Hospital Injectable Drugs Introduction 11.9.4 Teva Pharmaceutical Revenue in Hospital Injectable Drugs Business (2016-2021) 11.9.5 Teva Pharmaceutical Recent Development 11.10 Otsuka 11.10.1 Otsuka Company Details 11.10.2 Otsuka Business Overview 11.10.3 Otsuka Hospital Injectable Drugs Introduction 11.10.4 Otsuka Revenue in Hospital Injectable Drugs Business (2016-2021) 11.10.5 Otsuka Recent Development 11.11 B.Braun 11.11.1 B.Braun Company Details 11.11.2 B.Braun Business Overview 11.11.3 B.Braun Hospital Injectable Drugs Introduction 11.11.4 B.Braun Revenue in Hospital Injectable Drugs Business (2016-2021) 11.11.5 B.Braun Recent Development 11.12 JW Life Science 11.12.1 JW Life Science Company Details 11.12.2 JW Life Science Business Overview 11.12.3 JW Life Science Hospital Injectable Drugs Introduction 11.12.4 JW Life Science Revenue in Hospital Injectable Drugs Business (2016-2021) 11.12.5 JW Life Science Recent Development 11.13 Auromedics 11.13.1 Auromedics Company Details 11.13.2 Auromedics Business Overview 11.13.3 Auromedics Hospital Injectable Drugs Introduction 11.13.4 Auromedics Revenue in Hospital Injectable Drugs Business (2016-2021) 11.13.5 Auromedics Recent Development 11.14 Sanofi 11.14.1 Sanofi Company Details 11.14.2 Sanofi Business Overview 11.14.3 Sanofi Hospital Injectable Drugs Introduction 11.14.4 Sanofi Revenue in Hospital Injectable Drugs Business (2016-2021) 11.14.5 Sanofi Recent Development 11.15 Gland Pharma 11.15.1 Gland Pharma Company Details 11.15.2 Gland Pharma Business Overview 11.15.3 Gland Pharma Hospital Injectable Drugs Introduction 11.15.4 Gland Pharma Revenue in Hospital Injectable Drugs Business (2016-2021) 11.15.5 Gland Pharma Recent Development 11.16 Endo International PLC 11.16.1 Endo International PLC Company Details 11.16.2 Endo International PLC Business Overview 11.16.3 Endo International PLC Hospital Injectable Drugs Introduction 11.16.4 Endo International PLC Revenue in Hospital Injectable Drugs Business (2016-2021) 11.16.5 Endo International PLC Recent Development 11.17 Sichuan Kelun Pharmaceutical 11.17.1 Sichuan Kelun Pharmaceutical Company Details 11.17.2 Sichuan Kelun Pharmaceutical Business Overview 11.17.3 Sichuan Kelun Pharmaceutical Hospital Injectable Drugs Introduction 11.17.4 Sichuan Kelun Pharmaceutical Revenue in Hospital Injectable Drugs Business (2016-2021) 11.17.5 Sichuan Kelun Pharmaceutical Recent Development 11.18 Cisen Pharmaceutical 11.18.1 Cisen Pharmaceutical Company Details 11.18.2 Cisen Pharmaceutical Business Overview 11.18.3 Cisen Pharmaceutical Hospital Injectable Drugs Introduction 11.18.4 Cisen Pharmaceutical Revenue in Hospital Injectable Drugs Business (2016-2021) 11.18.5 Cisen Pharmaceutical Recent Development 11.18 Shijiazhuang No. 4 Pharmaceutical .1 Shijiazhuang No. 4 Pharmaceutical Company Details .2 Shijiazhuang No. 4 Pharmaceutical Business Overview .3 Shijiazhuang No. 4 Pharmaceutical Hospital Injectable Drugs Introduction .4 Shijiazhuang No. 4 Pharmaceutical Revenue in Hospital Injectable Drugs Business (2016-2021) .5 Shijiazhuang No. 4 Pharmaceutical Recent Development 11.20 Shandong Hualu Pharmaceutical 11.20.1 Shandong Hualu Pharmaceutical Company Details 11.20.2 Shandong Hualu Pharmaceutical Business Overview 11.20.3 Shandong Hualu Pharmaceutical Hospital Injectable Drugs Introduction 11.20.4 Shandong Hualu Pharmaceutical Revenue in Hospital Injectable Drugs Business (2016-2021) 11.20.5 Shandong Hualu Pharmaceutical Recent Development 11.21 CR Double-Crane 11.21.1 CR Double-Crane Company Details 11.21.2 CR Double-Crane Business Overview 11.21.3 CR Double-Crane Hospital Injectable Drugs Introduction 11.21.4 CR Double-Crane Revenue in Hospital Injectable Drugs Business (2016-2021) 11.21.5 CR Double-Crane Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Hospital Injectable Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Generic Sterile Injectables Table 3. Key Players of Sterile Intravenous (IV) Solutions Table 4. Global Hospital Injectable Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 5. Global Hospital Injectable Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 6. Global Hospital Injectable Drugs Market Size by Regions (2016-2021) & (US$ Million) Table 7. Global Hospital Injectable Drugs Market Share by Regions (2016-2021) Table 8. Global Hospital Injectable Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 9. Global Hospital Injectable Drugs Market Share by Regions (2022-2027) Table 10. Hospital Injectable Drugs Market Trends Table 11. Hospital Injectable Drugs Market Drivers Table 12. Hospital Injectable Drugs Market Challenges Table 13. Hospital Injectable Drugs Market Restraints Table 14. Global Hospital Injectable Drugs Revenue by Players (2016-2021) & (US$ Million) Table 15. Global Hospital Injectable Drugs Market Share by Players (2016-2021) Table 16. Global Top Hospital Injectable Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hospital Injectable Drugs as of 2020) Table 17. Ranking of Global Top Hospital Injectable Drugs Companies by Revenue (US$ Million) in 2020 Table 18. Global 5 Largest Players Market Share by Hospital Injectable Drugs Revenue (CR5 and HHI) & (2016-2021) Table 19. Key Players Headquarters and Area Served Table 20. Key Players Hospital Injectable Drugs Product Solution and Service Table 21. Date of Enter into Hospital Injectable Drugs Market Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global Hospital Injectable Drugs Market Size by Type (2016-2021) (US$ Million) Table 24. Global Hospital Injectable Drugs Revenue Market Share by Type (2016-2021) Table 25. Global Hospital Injectable Drugs Forecasted Market Size by Type (2022-2027) (US$ Million) Table 26. Global Hospital Injectable Drugs Revenue Market Share by Type (2022-2027) & (US$ Million) Table 27. Global Hospital Injectable Drugs Market Size Share by Application (2016-2021) & (US$ Million) Table 28. Global Hospital Injectable Drugs Revenue Market Share by Application (2016-2021) Table 29. Global Hospital Injectable Drugs Forecasted Market Size by Application (2022-2027) (US$ Million) Table 30. Global Hospital Injectable Drugs Revenue Market Share by Application (2022-2027) & (US$ Million) Table 31. North America Hospital Injectable Drugs Market Size by Type (2016-2021) (US$ Million) Table 32. North America Hospital Injectable Drugs Market Size by Type (2022-2027) & (US$ Million) Table 33. North America Hospital Injectable Drugs Market Size by Application (2016-2021) (US$ Million) Table 34. North America Hospital Injectable Drugs Market Size by Application (2022-2027) & (US$ Million) Table 35. North America Hospital Injectable Drugs Market Size by Country (2016-2021) & (US$ Million) Table 36. North America Hospital Injectable Drugs Market Size by Country (2022-2027) & (US$ Million) Table 37. Europe Hospital Injectable Drugs Market Size by Type (2016-2021) (US$ Million) Table 38. Europe Hospital Injectable Drugs Market Size by Type (2022-2027) & (US$ Million) Table 39. Europe Hospital Injectable Drugs Market Size by Application (2016-2021) (US$ Million) Table 40. Europe Hospital Injectable Drugs Market Size by Application (2022-2027) & (US$ Million) Table 41. Europe Hospital Injectable Drugs Market Size by Country (2016-2021) & (US$ Million) Table 42. Europe Hospital Injectable Drugs Market Size by Country (2022-2027) & (US$ Million) Table 43. Asia-Pacific Hospital Injectable Drugs Market Size by Type (2016-2021) (US$ Million) Table 44. Asia-Pacific Hospital Injectable Drugs Market Size by Type (2022-2027) & (US$ Million) Table 45. Asia-Pacific Hospital Injectable Drugs Market Size by Application (2016-2021) (US$ Million) Table 46. Asia-Pacific Hospital Injectable Drugs Market Size by Application (2022-2027) & (US$ Million) Table 47. Asia-Pacific Hospital Injectable Drugs Market Size by Region (2016-2021) & (US$ Million) Table 48. Asia-Pacific Hospital Injectable Drugs Market Size by Region (2022-2027) & (US$ Million) Table 49. Latin America Hospital Injectable Drugs Market Size by Type (2016-2021) (US$ Million) Table 50. Latin America Hospital Injectable Drugs Market Size by Type (2022-2027) & (US$ Million) Table 51. Latin America Hospital Injectable Drugs Market Size by Application (2016-2021) (US$ Million) Table 52. Latin America Hospital Injectable Drugs Market Size by Application (2022-2027) & (US$ Million) Table 53. Latin America Hospital Injectable Drugs Market Size by Country (2016-2021) & (US$ Million) Table 54. Latin America Hospital Injectable Drugs Market Size by Country (2022-2027) & (US$ Million) Table 55. Middle East & Africa Hospital Injectable Drugs Market Size by Type (2016-2021) (US$ Million) Table 56. Middle East & Africa Hospital Injectable Drugs Market Size by Type (2022-2027) & (US$ Million) Table 57. Middle East & Africa Hospital Injectable Drugs Market Size by Application (2016-2021) (US$ Million) Table 58. Middle East & Africa Hospital Injectable Drugs Market Size by Application (2022-2027) & (US$ Million) Table 59. Middle East & Africa Hospital Injectable Drugs Market Size by Country (2016-2021) & (US$ Million) Table 60. Middle East & Africa Hospital Injectable Drugs Market Size by Country (2022-2027) & (US$ Million) Table 61. Hospira (Pfizer Inc.) Company Details Table 62. Hospira (Pfizer Inc.) Business Overview Table 63. Hospira (Pfizer Inc.) Hospital Injectable Drugs Product Table 64. Hospira (Pfizer Inc.) Revenue in Hospital Injectable Drugs Business (2016-2021) & (US$ Million) Table 65. Hospira (Pfizer Inc.) Recent Development Table 66. Baxter Company Details Table 67. Baxter Business Overview Table 68. Baxter Hospital Injectable Drugs Product Table 69. Baxter Revenue in Hospital Injectable Drugs Business (2016-2021) & (US$ Million) Table 70. Baxter Recent Development Table 71. Fresenius Kabi Company Details Table 72. Fresenius Kabi Business Overview Table 73. Fresenius Kabi Hospital Injectable Drugs Product Table 74. Fresenius Kabi Revenue in Hospital Injectable Drugs Business (2016-2021) & (US$ Million) Table 75. Fresenius Kabi Recent Development Table 76. Sandoz (Novartis) Company Details Table 77. Sandoz (Novartis) Business Overview Table 78. Sandoz (Novartis) Hospital Injectable Drugs Product Table 79. Sandoz (Novartis) Revenue in Hospital Injectable Drugs Business (2016-2021) & (US$ Million) Table 80. Sandoz (Novartis) Recent Development Table 81. Hikma Pharmaceuticals PLC Company Details Table 82. Hikma Pharmaceuticals PLC Business Overview Table 83. Hikma Pharmaceuticals PLC Hospital Injectable Drugs Product Table 84. Hikma Pharmaceuticals PLC Revenue in Hospital Injectable Drugs Business (2016-2021) & (US$ Million) Table 85. Hikma Pharmaceuticals PLC Recent Development Table 86. Dr. Reddy’s Laboratories Ltd Company Details Table 87. Dr. Reddy’s Laboratories Ltd Business Overview Table 88. Dr. Reddy’s Laboratories Ltd Hospital Injectable Drugs Product Table 89. Dr. Reddy’s Laboratories Ltd Revenue in Hospital Injectable Drugs Business (2016-2021) & (US$ Million) Table 90. Dr. Reddy’s Laboratories Ltd Recent Development Table 91. Grifols Company Details Table 92. Grifols Business Overview Table 93. Grifols Hospital Injectable Drugs Product Table 94. Grifols Revenue in Hospital Injectable Drugs Business (2016-2021) & (US$ Million) Table 95. Grifols Recent Development Table 96. Nichi-Iko Group (Sagent) Company Details Table 97. Nichi-Iko Group (Sagent) Business Overview Table 98. Nichi-Iko Group (Sagent) Revenue in Hospital Injectable Drugs Business (2016-2021) & (US$ Million) Table 99. Nichi-Iko Group (Sagent) Recent Development Table 100. Teva Pharmaceutical Company Details Table 101. Teva Pharmaceutical Business Overview Table 102. Teva Pharmaceutical Hospital Injectable Drugs Product Table 103. Teva Pharmaceutical Revenue in Hospital Injectable Drugs Business (2016-2021) & (US$ Million) Table 104. Teva Pharmaceutical Recent Development Table 105. Otsuka Company Details Table 106. Otsuka Business Overview Table 107. Otsuka Hospital Injectable Drugs Product Table 108. Otsuka Revenue in Hospital Injectable Drugs Business (2016-2021) & (US$ Million) Table 109. Otsuka Recent Development Table 110. B.Braun Company Details Table 111. B.Braun Business Overview Table 112. B.Braun Hospital Injectable Drugs Product Table 113. B.Braun Revenue in Hospital Injectable Drugs Business (2016-2021) & (US$ Million) Table 114. B.Braun Recent Development Table 115. JW Life Science Company Details Table 116. JW Life Science Business Overview Table 117. JW Life Science Hospital Injectable Drugs Product Table 118. JW Life Science Revenue in Hospital Injectable Drugs Business (2016-2021) & (US$ Million) Table 119. JW Life Science Recent Development Table 120. Auromedics Company Details Table 121. Auromedics Business Overview Table 122. Auromedics Hospital Injectable Drugs Product Table 123. Auromedics Revenue in Hospital Injectable Drugs Business (2016-2021) & (US$ Million) Table 124. Auromedics Recent Development Table 125. Sanofi Company Details Table 126. Sanofi Business Overview Table 127. Sanofi Hospital Injectable Drugs Product Table 128. Sanofi Revenue in Hospital Injectable Drugs Business (2016-2021) & (US$ Million) Table 129. Sanofi Recent Development Table 130. Gland Pharma Company Details Table 131. Gland Pharma Business Overview Table 132. Gland Pharma Hospital Injectable Drugs Product Table 133. Gland Pharma Revenue in Hospital Injectable Drugs Business (2016-2021) & (US$ Million) Table 134. Gland Pharma Recent Development Table 135. Endo International PLC Company Details Table 136. Endo International PLC Business Overview Table 137. Endo International PLC Hospital Injectable Drugs Product Table 138. Endo International PLC Revenue in Hospital Injectable Drugs Business (2016-2021) & (US$ Million) Table 139. Endo International PLC Recent Development Table 140. Sichuan Kelun Pharmaceutical Company Details Table 141. Sichuan Kelun Pharmaceutical Business Overview Table 142. Sichuan Kelun Pharmaceutical Hospital Injectable Drugs Product Table 143. Sichuan Kelun Pharmaceutical Revenue in Hospital Injectable Drugs Business (2016-2021) & (US$ Million) Table 144. Sichuan Kelun Pharmaceutical Recent Development Table 145. Cisen Pharmaceutical Company Details Table 146. Cisen Pharmaceutical Business Overview Table 147. Cisen Pharmaceutical Hospital Injectable Drugs Product Table 148. Cisen Pharmaceutical Revenue in Hospital Injectable Drugs Business (2016-2021) & (US$ Million) Table 149. Cisen Pharmaceutical Recent Development Table 150. Shijiazhuang No. 4 Pharmaceutical Company Details Table 151. Shijiazhuang No. 4 Pharmaceutical Business Overview Table 152. Shijiazhuang No. 4 Pharmaceutical Hospital Injectable Drugs Product Table 153. Shijiazhuang No. 4 Pharmaceutical Revenue in Hospital Injectable Drugs Business (2016-2021) & (US$ Million) Table 154. Shijiazhuang No. 4 Pharmaceutical Recent Development Table 155. Shandong Hualu Pharmaceutical Company Details Table 156. Shandong Hualu Pharmaceutical Business Overview Table 157. Shandong Hualu Pharmaceutical Hospital Injectable Drugs Product Table 158. Shandong Hualu Pharmaceutical Revenue in Hospital Injectable Drugs Business (2016-2021) & (US$ Million) Table 159. Shandong Hualu Pharmaceutical Recent Development Table 160. CR Double-Crane Company Details Table 161. CR Double-Crane Business Overview Table 162. CR Double-Crane Hospital Injectable Drugs Product Table 163. CR Double-Crane Revenue in Hospital Injectable Drugs Business (2016-2021) & (US$ Million) Table 164. CR Double-Crane Recent Development Table 165. Research Programs/Design for This Report Table 166. Key Data Information from Secondary Sources Table 167. Key Data Information from Primary Sources List of Figures Figure 1. Global Hospital Injectable Drugs Market Share by Type: 2020 VS 2027 Figure 2. Generic Sterile Injectables Features Figure 3. Sterile Intravenous (IV) Solutions Features Figure 4. Global Hospital Injectable Drugs Market Share by Application: 2020 VS 2027 Figure 5. Oncology Case Studies Figure 6. Anesthesia Case Studies Figure 7. Anti-Infectives Case Studies Figure 8. Parenteral Nutrition Case Studies Figure 9. Cardiovascular Diseases Case Studies Figure 10. Hospital Injectable Drugs Report Years Considered Figure 11. Global Hospital Injectable Drugs Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 12. Global Hospital Injectable Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 13. Global Hospital Injectable Drugs Market Share by Regions: 2020 VS 2027 Figure 14. Global Hospital Injectable Drugs Market Share by Regions (2022-2027) Figure 15. Global Hospital Injectable Drugs Market Share by Players in 2020 Figure 16. Global Top Hospital Injectable Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hospital Injectable Drugs as of 2020 Figure 17. The Top 10 and 5 Players Market Share by Hospital Injectable Drugs Revenue in 2020 Figure 18. Global Hospital Injectable Drugs Revenue Market Share by Type (2016-2021) Figure 19. Global Hospital Injectable Drugs Revenue Market Share by Type (2022-2027) Figure 20. North America Hospital Injectable Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 21. North America Hospital Injectable Drugs Market Share by Type (2016-2027) Figure 22. North America Hospital Injectable Drugs Market Share by Application (2016-2027) Figure 23. North America Hospital Injectable Drugs Market Share by Country (2016-2027) Figure 24. United States Hospital Injectable Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Canada Hospital Injectable Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. Europe Hospital Injectable Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 27. Europe Hospital Injectable Drugs Market Share by Type (2016-2027) Figure 28. Europe Hospital Injectable Drugs Market Share by Application (2016-2027) Figure 29. Europe Hospital Injectable Drugs Market Share by Country (2016-2027) Figure 30. Germany Hospital Injectable Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. France Hospital Injectable Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. U.K. Hospital Injectable Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Italy Hospital Injectable Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Russia Hospital Injectable Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Nordic Hospital Injectable Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Asia-Pacific Hospital Injectable Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. Asia-Pacific Hospital Injectable Drugs Market Share by Type (2016-2027) Figure 38. Asia-Pacific Hospital Injectable Drugs Market Share by Application (2016-2027) Figure 39. Asia-Pacific Hospital Injectable Drugs Market Share by Region (2016-2027) Figure 40. China Hospital Injectable Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. Japan Hospital Injectable Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. South Korea Hospital Injectable Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Southeast Asia Hospital Injectable Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. India Hospital Injectable Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Australia Hospital Injectable Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Latin America Hospital Injectable Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. Latin America Hospital Injectable Drugs Market Share by Type (2016-2027) Figure 48. Latin America Hospital Injectable Drugs Market Share by Application (2016-2027) Figure 49. Latin America Hospital Injectable Drugs Market Share by Country (2016-2027) Figure 50. Mexico Hospital Injectable Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Brazil Hospital Injectable Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Middle East & Africa Hospital Injectable Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 53. Middle East & Africa Hospital Injectable Drugs Market Share by Type (2016-2027) Figure 54. Middle East & Africa Hospital Injectable Drugs Market Share by Application (2016-2027) Figure 55. Middle East & Africa Hospital Injectable Drugs Market Share by Country (2016-2027) Figure 56. Turkey Hospital Injectable Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. Saudi Arabia Hospital Injectable Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. UAE Hospital Injectable Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 59. Hospira (Pfizer Inc.) Revenue Growth Rate in Hospital Injectable Drugs Business (2016-2021) Figure 60. Baxter Revenue Growth Rate in Hospital Injectable Drugs Business (2016-2021) Figure 61. Fresenius Kabi Revenue Growth Rate in Hospital Injectable Drugs Business (2016-2021) Figure 62. Sandoz (Novartis) Revenue Growth Rate in Hospital Injectable Drugs Business (2016-2021) Figure 63. Hikma Pharmaceuticals PLC Revenue Growth Rate in Hospital Injectable Drugs Business (2016-2021) Figure 64. Dr. Reddy’s Laboratories Ltd Revenue Growth Rate in Hospital Injectable Drugs Business (2016-2021) Figure 65. Grifols Revenue Growth Rate in Hospital Injectable Drugs Business (2016-2021) Figure 66. Nichi-Iko Group (Sagent) Revenue Growth Rate in Hospital Injectable Drugs Business (2016-2021) Figure 67. Teva Pharmaceutical Revenue Growth Rate in Hospital Injectable Drugs Business (2016-2021) Figure 68. Otsuka Revenue Growth Rate in Hospital Injectable Drugs Business (2016-2021) Figure 69. B.Braun Revenue Growth Rate in Hospital Injectable Drugs Business (2016-2021) Figure 70. JW Life Science Revenue Growth Rate in Hospital Injectable Drugs Business (2016-2021) Figure 71. Auromedics Revenue Growth Rate in Hospital Injectable Drugs Business (2016-2021) Figure 72. Sanofi Revenue Growth Rate in Hospital Injectable Drugs Business (2016-2021) Figure 73. Gland Pharma Revenue Growth Rate in Hospital Injectable Drugs Business (2016-2021) Figure 74. Endo International PLC Revenue Growth Rate in Hospital Injectable Drugs Business (2016-2021) Figure 75. Sichuan Kelun Pharmaceutical Revenue Growth Rate in Hospital Injectable Drugs Business (2016-2021) Figure 76. Cisen Pharmaceutical Revenue Growth Rate in Hospital Injectable Drugs Business (2016-2021) Figure 77. Shijiazhuang No. 4 Pharmaceutical Revenue Growth Rate in Hospital Injectable Drugs Business (2016-2021) Figure 78. Shandong Hualu Pharmaceutical Revenue Growth Rate in Hospital Injectable Drugs Business (2016-2021) Figure 79. CR Double-Crane Revenue Growth Rate in Hospital Injectable Drugs Business (2016-2021) Figure 80. Bottom-up and Top-down Approaches for This Report Figure 81. Data Triangulation Figure 82. Key Executives Interviewed

Hospira (Pfizer Inc.) Baxter Fresenius Kabi Sandoz (Novartis) Hikma Pharmaceuticals PLC Dr. Reddy’s Laboratories Ltd Grifols Nichi-Iko Group (Sagent) Teva Pharmaceutical Otsuka B.Braun JW Life Science Auromedics Sanofi Gland Pharma Endo International PLC Sichuan Kelun Pharmaceutical Cisen Pharmaceutical Shijiazhuang No. 4 Pharmaceutical Shandong Hualu Pharmaceutical CR Double-Crane